Jump to Navigation
Quantitative
Research
Quantitative Models
Methodology Graphic
EQR White Paper
Investment
Products
Sabrient QES Index Series
Baker's Dozen Model Portfolio
UITs
ETFs
Investor
Tools
Scorecards
Earnings Busters
Sector Detector
Advisors &
Individual Investors
Go to Investors Site
About Us
Our Company
Our People
ADV2A
Contact Us
Search form
Search
You are here:
You are here
Home
»
Feed aggregator
»
Sources
https://seekingalpha.com
URL:
https://seekingalpha.com
Updated:
18 min 34 sec ago
Warning: ASNS is at high risk of performing badly
Tue, 03/31/2026 - 06:03
Eli Lilly to acquire Centessa in deal worth up to $47 per share; CNTA rallies 47%
Tue, 03/31/2026 - 06:03
Nasdaq slashes waiting period for IPOs in major index overhaul
Tue, 03/31/2026 - 06:03
Sandisk: TurboQuant Fears Miss The Bigger Picture
Tue, 03/31/2026 - 06:00
South Korean chipmakers' helium reserves to last until at least June: report
Tue, 03/31/2026 - 05:03
Nokia secures major 5G RAN deal with Virgin Media O2 to drive mobile transformation plan
Tue, 03/31/2026 - 04:13
ASE Technology: The Next Era Of Advanced Packaging Is Here
Tue, 03/31/2026 - 04:07
AUD/USD Downtrend Remains Intact Below 0.6910 Despite Trump's Iran War Exit Remarks
Tue, 03/31/2026 - 04:05
Euro Area inflation rises to 2.5% in March
Tue, 03/31/2026 - 04:04
PetroChina Company Limited 2025 Q4 - Results - Earnings Call Presentation
Tue, 03/31/2026 - 04:01
Biggest stock movers: SPCE, MKC, and more
Tue, 03/31/2026 - 04:01
Phreesia, Inc. 2026 Q4 - Results - Earnings Call Presentation
Tue, 03/31/2026 - 04:00
Andrew Hill Investment Advisors Q1 2026 Client Letter
Tue, 03/31/2026 - 04:00
PagerDuty: A Clear 'Sell' As Churn Issue Worsens (Downgrade)
Tue, 03/31/2026 - 04:00
Sherritt International to raise $50M via non-brokered private placement
Tue, 03/31/2026 - 03:59
MINISO Group beats Q4 street view
Tue, 03/31/2026 - 03:59
Rates Spark: Pessimism Sets The Tone In Markets
Tue, 03/31/2026 - 03:55
European stocks edge higher but set for worst month since 2020
Tue, 03/31/2026 - 03:50
Iovance Biotherapeutics: Competition Afoot, But New Indications Can Help
Tue, 03/31/2026 - 03:43
PepGen Inc. (PEPG) Discusses Topline Results From Lowest Dose MAD Cohort in Phase II FREEDOM2 Study With Favorable Safety, Splicing and vHOT Data - Slideshow
Tue, 03/31/2026 - 03:31
Pages
« first
‹ previous
…
1844
1845
1846
1847
1848
1849
1850
1851
1852
…
next ›
last »